Profile image of Avesh J. Thuluvath, MD

Avesh J. Thuluvath, MD


Liver & Abdominal Transplant Surgery
Liver Disease
Liver Transplant
Transplant Hepatology
Transplant Surgery


Dr. Avesh J. Thuluvath is a transplant hepatologist and physician-scientist with expertise in caring for patients with liver disease. Dr. Thuluvath specializes in the diagnosis and treatment of viral hepatitis, metabolic dysfunction-associated steatotic liver disease, alcohol-associated liver disease and autoimmune liver diseases. He has additional expertise in the care of patients before and after liver transplantation. Dr. Thuluvath's clinical practice is centered on delivering high quality, personalized and patient-centered care for those with liver disease.

Prior to joining the faculty at Columbia University Medical Center, Dr. Thuluvath completed his Gastroenterology and Transplant Hepatology training at Northwestern University Feinberg School of Medicine. His additional research training includes an NIH post-doctoral fellowship in liver transplant outcomes research and a Masters in Clinical Investigation.

Dr. Thuluvath's research focuses on further elucidating the pathophysiology of frailty and sarcopenia in cirrhosis, with the ultimate goal of developing patient-centered interventions to optimize physical conditioning before liver transplantation.


Johns Hopkins Golden Heart, 2018

AASLD Emerging Liver Scholars Award, 2017

Johns Hopkins Bayview Gastroenterology and Hepatology Scholar, 2017-2018

Honors Program in Medical Education (HPME), 2008-2016


Thuluvath AJ, Duarte-Rojo A, Lai JC, Peipert J, Dietch Z, Siddiqui O, Morrissey S, Belfanti K, Zhao L, Guo K, Nizamuddin M, Polineni P, Levitsky J, Flores AM, Ladner DP. Brief PROMIS Assessment Screens for Frailty and Predicts Hospitalizations in Liver Transplant Candidates. Transplantation.

Thuluvath AJ, Kim M, Peipert J, Duarte-Rojo A, Huang A, Siddiqui O, Nizamuddin M, Dietch Z, Levitsky J, Ladner DP. Patient-Reported Outcome Screens for Hepatic Encephalopathy and Predicts Admissions in Cirrhosis. Hepatol Res.

Siddiqui O, Lin KA, Najam N, Shah T, Beestrum ML, Thuluvath AJ, Bonakdarpour B, Kim M, Ladner DP. Cognitive Impairment in Liver Transplant Recipients with a History of Cirrhosis: A Systematic Review. Liver Transpl.

Thuluvath AJ, Lai JC. Understanding Current Limitations to Exercise Interventions after Liver Transplantation. Transplantation. 2022; in press.

Thuluvath AJ, Siddiqui O, Lai JC, Peipert J, Levitsky J, Daud A, Mazumder NR, Flores AM, Borja-Cacho D, Caicedo JC, Loftus C, Wong, R, Mroczek D, Ladner DP. Personality Traits in Patients with Cirrhosis are Different from Those of the General Population and Impact Likelihood of Liver Transplantation. Transplantation. 2022; in press.

Thuluvath AJ, Peipert J, Berkowitz R, Siddiqui O, Whitehead B, Thomas A, Levitsky J, Caicedo-Ramirez J, Ladner DP. Donor quality of life after living donor liver transplantation: a review of the literature. Dig Med Res. 2021 Sep;4:49. doi: 10.21037/dmr-20-151; PMID: 35252845.

Thuluvath AJ, Ahn JC, Rattan P, Kurdi AT, Peeraphatdit TB, Kamath MJ, Lennon RJ, Poterucha JJ, Petersen BT, Kamath PS. Evaluation of Charcot Triad, Reynolds Pentad, and Tokyo Guidelines for Diagnosis of Cholangitis Secondary to Choledocholithiasis Across Patient Age Groups. Mayo Clin Proc Innov Qual Outcomes. 2021 Apr 8;5(2):377-387; PMID: 33997636.

Thuluvath AJ, Savva Y, Chen PH. Poor graft and patient survival after liver transplantation in sarcoidosis. J Clin Gastroenterol. 2020 Nov/Dec;54(10):884-890; PMID: 33027134.

Thuluvath AJ, Chen PH, Thuluvath PJ, Kantsevoy S, Savva Y. Poor survival after retransplantation in NASH cirrhosis. Transplantation. 2019 Jan;103(1):101-108; PMID: 29470354.

John GK, Thuluvath AJ, Carrier H, Ahuja NK, Gupta E, Stein E. Poor health literacy and medication burden are significant predictors for inadequate bowel preparation in the urban tertiary care setting. J Clin Gastroenterol. 2019 Oct;53(9):e382-e386; PMID: 30789854.

Kantsevoy SV, Wagner A, Mitrakov AA, Thuluvath AJ, Berr F. Rectal reconstruction after endoscopic submucosal dissection for removal of a giant rectal lesion. VideoGIE. 2019 Jan 31;4(4):179-181; PMID: 31032467.

Kantsevoy SV, Raina A, Thuluvath AJ, Thuluvath PJ. Traction Facilitates Endoscopic En Bloc Removal of Appendiceal Polyp. VideoGIE. 2019 Jan 17;4(3):136-139; PMID: 30899895.

Thuluvath PJ, Kantsevoy S, Thuluvath AJ, Savva Y. Is cryptogenic cirrhosis different from NASH cirrhosis? J Hepatol. 2018 Mar; 68 (3): 519-525; PMID: 29162389.

Thuluvath PJ, Thuluvath AJ, Hanish S, Savva Y. Liver transplantation in patients with multiple organ failures: Feasibility and outcomes. J Hepatol. 2018 Nov;69(5):1047-1056; PMID: 30071241.

Thuluvath PJ, Thuluvath AJ, Savva Y. Karnofsky Performance Status before and after liver transplantation predicts graft and patient survival. J Hepatol. 2018 Oct;69(4):818-825; PMID: 29883596.

Hillman L, Yadlapati R, Whitsett M, Thuluvath AJ, Berendsen MA, Pandolfino JE. Review of antireflux procedures for proton pump inhibitor nonresponsive gastroesophageal reflux disease. Dis Esophagus. 2017 September; 30 (9): 1-14; PMID: 28859357.

Hillman L, Yadlapati R, Thuluvath AJ, Berendsen MA, Pandolfino JE. A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease. Dis Esophagus. 2017 September; 30 (9): 1-15; PMID: 28859358.

Gordon AC, Gradishar WJ, Kaklamani VG, Thuluvath AJ, Ryu RK, Sato KT, Gates VL, Salem R, Lewandowski RJ. Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy. J Vasc Interv Radiol. October 2014; 25 (10): 1523-32; PMID: 25156827.

Olino K, Edil BH, Meckel KF, Pan X, Thuluvath AJ, Pardoll DM, Schulick RD, Yoshimura K, Weber WP. Glycolipid antigens for treating hepatic colorectal cancer metastases and their effect on the therapeutic efficacy of live attenuated listeria monocytogenes. Arch of Surg. May 2012; 147 (5): 480-482; PMID: 22785644.